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ABSTRACT
Objectives: Some of the patients with chronic hepatitis use both alternative product and/or antiviral treatment. These 
herbal products sometimes lead to clinical deterioration. In this study we aimed to determine the purpose of alternative 
product utilization and rate among the chronic hepatitis B (CHB) and C (CHC) patients.
Methods: This prospective cohort study included 200 consecutive adult patients with chronic hepatitis B and C at the 
Department of Infectious Diseases, Ondokuz Mayis University, between 1 March 2012 and 30 July 2012. At enrollment, 
clinical information, demographics, laboratory variables and knowledge about alternative products were recorded.
Results: Of the patients 150 had CHB, 50 had CHC. 54% of patients were male. Use of alternative products was 26%. 
Antiviral treatment rate was 48.5% for all patients. The most used alternative products were artichoke extract and honey. 
67.3% of patients were using single alternative product whereas the others were using two or more alternative products. 
46.2% of patients who use alternative product provided information about the alternative product usage, but the others 
did not.
Conclusions: Majority of patients used alternative products. More than half of these patients did not give information 
to their physicians about their use of alternative medicine. Use of alternative product should be asked in all patients 
with chronic hepatitis.
Herbal product usage was detected in majority of patients and also approximately half of these patients did not give 
information to their doctors about taking alternative medicine. In conclusion, it is necessary to take detailed information 
about herbal product usage in patients with chronic hepatitis. J Microbiol Infect Dis 2014; 4(3): 102-106
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Kronik viral hepatitli hastalarda alternatif ürün kullanımı
ÖZET 
Amaç: Kronik hepatitli hastalar antiviral ilaç tedavisiyle beraber alternatif ürünleride kullanabilirler. Alternatif ürünler 
bazen klinik kötüleşmeye yol açabilir. Bu çalışmada kronik hepatit B (KHB) ve kronik hepatit C (KHC)’li hastaların alternatif 
ürün kullanımını ve sıklıklarını belirlemeyi amaçladık. 
Yöntemler: Bu prospektif kohort çalışmaya Ondokuz Mayıs Üniversitesi Enfeksiyon Hastalıkları Klinik Mikrobiyoloji po-
likliniğinde 1 Mart-30 Temmuz 2012 tarihleri arasında kronik hepatit B ve C tanısı ile izlenen 200 yetişkin hasta dahil 
edildi. Hastaların klinik bilgileri, demografik, laboratuvar değerleri ve alternatif ürün kullanma bilgileri kaydedildi. 
Bulgular: Hastalarımızın 150’inde KHB ve 50’inde KHB infeksiyonu olup % 54’ü erkekti. Alternatif ürün kullanım oranı 
% 26 idi. Bütün hastalarda antiviral tedavi kullanım oranı % 48,5’idi. En sık kullanılan alternatif ürünler enginar ve baldı. 
Hastaların % 67,3’ü sadece bal kullanırken, diğerleri iki veya daha fazla alternatif ürün kullanıyordu. Alternatif ürün kul-
lanan hastaların sadece % 46,2’si ilk sorgulamada ürün kullanımı hakkında bilgiyi verirken diğerleri vermedi.
Sonuç: Çalışmaya alınan hastaların çoğunluğunda alternatif ürün kullanımı belirlenirken hastaların yarısı alternatif ürün 
kullandıkları hakkında doktoruna bilgi vermedi. Sonuç olarak kronik hepatitli her hastada alternatif ürün kullanımı de-
taylı şekilde sorgulanmalıdır.
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INTRODUCTION
Chronic viral hepatitis is a disease that can cause 
cirrhosis, hepatocellular carcinoma and sometimes 
death. Due to its characteristic chronic nature, 
therapeutic challenges and the complexity of the 
management of complications, and because of rel-
atively long duration of treatment and higher costs, 
patients may be referred to alternative treatment 
methods. According to World Health Organization 
(WHO) report 70-80% of the world population could 
be referred to herbal products in practices of basic 
health services.1,2
Today, scientific developments based on evi-
dence for the diagnosis and treatment of diseases 
made people live longer and thus the number of 
people with chronic diseases increased. Phytoth-
eraphy, which is an alternative medical practice, 
described as using plants in various forms for thera-
peutic purposes. Plants have been used extensive-
ly in the worldwide and the origin of phytotheraphy 
goes back to ancient times. Deficient scientific re-
search about herbal medicines, legal flaws, insuf-
ficient control mechanism, tremendous information 
pool and the broadcasting by visual and printed 
tools have become important in terms of comple-
mentary and alternative medicine (CAM) to consid-
er public health.3
This study was conducted on patients with 
chronic viral hepatitis who were admitted to our 
clinic for treatment and follow up, and the frequency 
and duration of CAM use, informative sources pa-
tients preference, and the awareness of their per-
sonal physicians about using such an alternative 
therapy were predicted. 
METHODS
This cross-sectional study was held on patients 
who admitted to Department of Infectious Diseas-
es, Ondokuz Mayis University School of Medicine 
between March 1, 2012 and July 30, 2012. A total 
of 200 patients with chronic hepatitis B and C who 
were under or completed antiviral treatment during 
follow-up period and patients with inactive hepatitis 
B on follow-up without treatment were included in 
this study. The uniquely questionnaire developed 
for this study included questions such as the pa-
tients’ demographic characteristics, information 
level about chronic hepatitis and the use of herbal 
medicine. Patients were interviewed personally and 
the questionnaires were completed with the con-
sent of patients. Patients younger than 18 years old 
were excluded from the study. Descriptive statistics 
have been expressed as an arithmetic mean ± stan-
dard deviation and percentage in discrete variables. 
This study was approved by the Institutional Review 
Board.
RESULTS
Of the 200 patients included in the study, 54% were 
male, 46% were female. 75% of the patients had 
chronic hepatitis B (CHB) and 25% had chronic 
hepatitis C (CHC). CAM use rate was detected 26% 
of patients. 67.3% of patients used only alternative 
products, while the number of patients who used two 
or more products was 32.7%. The most commonly 
used alternative products were artichoke (44.2%), 
honey (28.8%) and parsley extract (15.4%) respec-
tively. The most popular CAM products are present-
ed in Table 1.
Table 1. Alternative products used by patients
Name of product Number of patient (%)
Artichoke 23 (44.2)
Honey 15 (28.8)
Parsley  8 (15.3)
Ready preparate + artichoke 6 (11.5)
Lavender 3 (5.7)
Ginger + pomegranate juice 3 (5.7)
Urtica urens + parsley 3 (5.7)
Green tea 3 (5.7)
Broccoli 2 (3.8)
Thistle 2 (3.8)
Taraxacum 2 (3.8)
Curcuma+pomegranate juice 2 (3.8)
Others (Aquamarine juice, 
Celery, Grape molasses) 5 (9.6)
Considering the education level of patients, 
7.7% were found to be illiterate, 42.3% primary 
school graduates, 32.6% secondary and high 
school graduates and 17.3 % college graduates re-
spectively. No statistically significant difference was 
found between education level and alternative prod-
uct usage. 53.8% of the patients revealed that they 
informed their physicians about the product they 
used, whereas the other 46.2% not. 75% of patients 
using complementary and alternative products were 
reportedly satisfactory with conventional non-medi-
cal alternative treatment. 34.6% of patients indicat-Dulger M, et al. Use of alternative product in patients with chronic viral hepatitis 104
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ed radio and television broadcasts as their source 
of information and 34.6% stated their source as the 
internet. In addition, other sources of information 
were the recommendations of people with similar 
diseases, neighbors, relatives and friends. 
Considering the frequency of using alternative 
herbal products, 50% of patients reported that they 
used them every day, 26.9% used these products 
irregularly, 19.2% 2-3 times a week and 3.8% used 
once a month respectively. The length of usage time 
was as follows: in 38.5% 1-3 months, in 25% 4-12 
months, in 17.3 % less than 1 month and in 17.3% 
more than one year respectively. On the other hand, 
7.5% of patients reported no use of antiviral treat-
ment but only herbal products. Of the patients, 
50.5% underwent medical treatment and 18.5% 
received both antiviral treatments and CAM and 
23.5% did not receive any. It was found that, 39.2% 
of patients had performed no systematic investiga-
tion about the usage of herbal products. 
No statistically significant difference was found 
considering prior and after treatment PCR HBV 
DNA, PCR HCV RNA values and ALT levels in pa-
tients using only CAM (p=0.160, p=0.230). Con-
versely, a significant difference was found between 
the pre and post treatment PCR HBV DNA and PCR 
HCV RNA, ALT values of the chronic viral hepati-
tis B and C patients who had antiviral treatment 
(p=0.001).
Of patients 75% under follow-up with the treat-
ment of chronic viral hepatitis and using CAM, re-
ported that they believed in the therapeutic effect of 
alternative products due to broadcasts (13.5%), rec-
ommendations of patients (36.5%) and decreased 
confidence in medical treatment (3%).
DISCUSSION
Patients with hepatitis carry some risks about us-
ing herbal products. Herbal products can cause 
hepatotoxicity in people who does not have hepa-
titis before. Major herbal products that cause toxic 
hepatitis are xiao-chai-hu-tang, basil, teucrium po-
lium, briar patch, senna, mistletoe, scutellaria lateri-
folia, gentian, comfrey (includes pyrrolizidine alka-
loid) and herbal teas. Recently, well defined acute 
hepatitis-like disorder resulting from use of ‘jin bu 
huan’ has been reported. High doses of vitamin A 
can cause liver damage. In addition, it has been re-
ported that pyrrolizidine alkaloids in Chinese herbal 
mixtures can cause veno-occlusive liver disease.4 
In our study, 26% of 200 patients with chronic hepa-
titis reportedly used alternative products.
White et al. reported in a study with 76 patients 
with chronic viral hepatitis C, 28% of patients used 
vitamin or mineral supplement, 24% used herbal 
products which were similar rates in our study and 
18% were reported to seek other natural treatment 
methods such as acupuncture.5 They reported 
mostly used herbal products as milk-thistle (56%), 
evening primrose oil (17%) and glucosamine sup-
plement (11%) respectively. Considering patients 
using herbs, 72% used only one product, whereas 
17% used two and 11% used three different prod-
ucts concurrently. Sources of herbs were pharmacy 
in 83%, and market in 17%. In patients using CAM, 
68% gained information about how to use from su-
permarkets, 16% from the internet, 8% from books, 
4% from alternative medicine specialists and 4% 
from physicians. None of patients who used CAM 
were reported to have side effects. They found that, 
83% of people reached CAM by pharmacies and 
supermarkets. Most frequently used triple herbal 
products were milk-thistle, evening primrose oil and 
glucosamine supplement. Our study revealed that, 
broadcasting by radio and television had a major 
impact in 69.2% of patients in reaching herbal prod-
ucts. Most of the products used were artichoke, 
honey and parsley respectively.
In another study, Ferruci et al.6 found that, 248 
of 1040 patients with chronic hepatitis used at least 
one CAM method. Of patients, 188 preferred vita-
min and food supplements, 175 preferred herbal 
products and 16 preferred homoeopathy whereas 
86 patients used multiple CAM treatment modali-
ties. Most widely used herbal products were milk-
thistle (43.8%), St. Aaron’s beard (10.7%), echi-
nacea (8.9%) and valerian (4.5%) respectively. 
They revealed that, CAM use was found to be sig-
nificantly higher in patients with a story of hepatitis 
C and alcohol, hepatitis B and only alcohol when 
compared with patients who had non-alcoholic 
hepatosteatosis and steatorrhoeic hepatosis. CAM 
use and demographic characteristics were found 
to have a significant relationship with parameters 
such as male gender, young age, level of educa-
tion, level of income and hospitalization. This study 
was similar to our findings in that the patients had 
a rate of 23.8% CAM use which was very close to 
our results. However, unlike our study, Ferruci et 
al.6 found a significant relationship between CAM 
use and demographic characteristics, male gender, 
young age, level of education, level of income and 
hospitalization. We did not find any significant differ-
ence in patients who used these products in terms 
of age, gender and level of education. In addition, Dulger M, et al. Use of alternative product in patients with chronic viral hepatitis 105
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no hepatotoxicity due to the products was found. Al-
though, the products patients used were not agents 
reported as hepatotoxic, we observed unexplained 
liver enzyme increases in 3 patients undergoing 
antiviral treatment and in patients who had positive 
response parameters. 
Seeff et al.7 reported that 235 of 1145 patients 
with chronic hepatitis C used herbal products in the 
past while 269 of them were using herbal products 
during the follow-up. Majority of patients reported 
usage of more than 60 herbs in various combina-
tions. These were mainly silymarin (72%), green 
tea (13.7%) and garlic (10.7%) in 269 patients. 
They  indicated  no  significant  difference  between 
patients who used silymarin and those who did not 
(p=0.08). Conversely, serum ALT levels were found 
to be significantly higher in users of silymarin than 
those of non users (p=0.04). They concluded that, 
in patients with hepatic injuries, silymarin use arised 
from the belief that it had a protective effect in liver 
damage caused by Amanita phalloides toxicity. Si-
lymarin demonstrated no antiviral activity against 
chronic hepatitis C virus.6 Although, both studies 
showed different CAM choices considering herbal 
products, no significant relationship was found be-
tween herbal products and PCR HCV RNA and ALT. 
In addition, aforementioned study was largely di-
rected about the efficacy of silymarin, on the other 
hand, in our study, the rate of using alternative prod-
ucts in 200 consecutive patients with chronic viral 
hepatitis was 26%. Of patients, 53.8% stated that, 
they informed their physicians about herbal product 
use whereas 46.2% did not. All patients in our study 
used herbs for the aim of treatment. 
In another study from China, 80% of patients 
with chronic hepatitis were reported to demand tra-
ditional Chinese medical products as well as inter-
feron and nucleoside analogs. An internet based 
review study in China found that, the most used 
herbal product was Mongolian milk vetch root.8 In 
our study, majority of patients used only one prod-
uct while some patients used multiple concurrently. 
A questionnaire of 310 patients applied by family 
physician recently in Ankara revealed that, 84.5% 
of patients were interested in herbal treatment and 
they used such treatment in the past. Of these pa-
tients, 21.6% used herbal products for a healthier 
life and as a vitamin supplement while 40% used for 
the treatment. This study also revealed that, 62.9% 
of patients gained information about herbal medi-
cine through media and 42.6% from friends and 
neighbours.9 Similarly, we found that, majority of 
patients stated that, they had information from the 
internet (34.6%), radio-television (34.6%), relatives-
neighbors (25%) while only 3.8% indicated similar 
patients as their source of information. 
Why do so many patients need to divert stan-
dard treatment modalities? Factors such as the dif-
ficulties in the treatment may have directed patients 
to different alternative methods. The well-known 
chronic course of the disease, prolonged treatment 
duration and the side effects of interferons used in 
hepatitis C may have led to psychiatric problems.10
Some studies from the United States revealed 
that, patients using herbal products were in gener-
ally female, highly educated and over 60 years.10,11 
We did not find any statistically significant difference 
between patients in terms of age, gender and level 
of education. We found that, of patients 39.2% had 
performed no systematic investigation about the us-
age of herbal products, exhibiting that people still 
rely on chit chat rather than scientific data. In addi-
tion, majority of patients did not inform their physi-
cians about usage and these yielded unfavorable 
results such as side effects or drug interaction. 
Therefore, physicians should ask about the use of 
such CAM methods. Besides, it should also be re-
membered that, patients who use herbal products 
can hinder their principal treatment. 
Some herbs can have positive psychological 
effects such as elimination of exhaustion and cause 
a general feeling of well-being. However, it should 
be kept in mind that these substances can interact 
with the patient’s medication and lead to alteration 
in drug levels.12,13
In conclusion, the use of alternative medical 
products in patients with chronic hepatitis repre-
sents a challenge for public health. Patients who 
do not inform their personal physicians about the 
use of herbal products, uncontrolled sales, benefit-
oriented  advertisements  lacking  scientific  basis 
and people’s recommendations make this situation 
more complicated. Health authorities, physicians 
and broadcast staff are all responsible to lead peo-
ple and patients in a true scientific manner. 
Completing interest
The authors declare that they have no competing 
interest.
REFERENCES
1. Traditional Medicine. http://www.who.int/mediacentre/fact-
sheets/fs134/en/ Accessed October 1,2012.
2. Sarısen O, Caliskan D. Fitoterapi: Bitkilerle tedaviye dikkat. 
Sted 2005; 14:182-187.Dulger M, et al. Use of alternative product in patients with chronic viral hepatitis 106
J Microbiol Infect Dis   www.jmidonline.org   Vol 4, No 3, September 2014
3. Gürün MS. Bitkisel tıp. ANKEM Derg 2004; 18:133-136.
4. Dienstang JL, Isselbacher KJ. Toxic and Drug-induced Hepa-
titis. Principles of Internal Medicine, 16th edn. McGraw-Hill: 
Kasper DL, 2005;1843-1844.
5. White CP, Hirsch G, Patel S, et al. Complementary and al-
ternative medicine use by patients chronically infected with 
hepatitis C virus. Can J Gastroenterol 2007;21:589-595.
6. Ferrucci LM, Bell BP, Dhotre KB, et al. Complementary and 
alternative medicine use in Chronic Liver Disease Patients. J 
Clin Gasroenterol 2010;44:40-45.
7. Seeff LB, Curto TM, Szabo G, et al. Herbal product use by per-
sons enrolled in the hepatitis C antiviral long-term treatment 
against cirrhosis trial. Hepatology 2008;47:605-612.
8. Zhang L, Wang G, Hou W, et al. Contemporary clinical re-
search of traditional Chinese medicines for chronic hepatitis 
B in China: an analytical review. Hepatology 2010;51:690-
698.
9. Gamsizkan Z, Yücel A, Kartal M. Using of herbal product. Jour-
nal of Clinical and Analytical Medicine 2012;3:300-302.
10. Schaefer M, Capuron L, Friebe A, et al. Hepatitis C infection, 
antiviral  treatment  and  mental  health:  a  European  expert 
consensus statement. J Hepatol 2012;57:1379-1390.
11. Bardia A, Nisly NL, Zimmerman MB, et al. Use of herbs 
among adults based on evidence-based indications: findings 
from the National Health Interview Survey. Mayo Clin Proc 
2007;82:561-566. 
12. Kennedy J. Herb and supplement use in the US Population. 
Clin Therap 2005;27:1847-1858.
13. Meisel C, Johne A, Roots I. Fatal intracerebral mass bleed-
ing associated with G. biloba and ibuprofen. Atherosclerosis 
2003;167:367.